SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Peter Singleton who wrote (4403)5/29/1998 2:31:00 PM
From: Izzy  Read Replies (1) of 6136
 
Any response to the verdict that AGPH was found guilty of "academic espionage" by stealing "potentially valuable research" from a UCSD researcher? The drug effort apparently failed and had nothing to do with the development of Viracept. "This is believed to be the first time a commercial firm was found to have misappropriated biotechnology secrets from a UCSD lab." Do you think that this is may be an industry wide issue that may apply to other biotech companies and how harmful, if any, is this jury decision on AGPH?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News